Skip to main content
. 2023 Apr 11;24(8):7048. doi: 10.3390/ijms24087048

Figure 13.

Figure 13

(AF) Percentage of CD8 naïve cells producing IFN-γ, IL-10, IL-17, IL-9, TNF-α, and IL-2 in healthy controls (HC); chronic SCI patients with short periods of evolution (<5 years) (SCI-SP); chronic SCI patients in early chronic phase (5 to 15 years) (SCI-ECP); and chronic SCI patients in late-chronic phase (>15 years) (SCI-LCP). We use ‘*’ to distinguish between chronic SCI patients and HC. p < 0.05 (*), p < 0.01 (**).